Editorial: Portal Hypertension in Cirrhosis: From Pathogenesis to Novel Treatments
- PMID: 35388286
- PMCID: PMC8978555
- DOI: 10.3389/fphys.2022.864083
Editorial: Portal Hypertension in Cirrhosis: From Pathogenesis to Novel Treatments
Keywords: cirrhosis; liver stiffness measurement (LSM); macrophage activation markers; novel treatment; pathophysiology of cirrhosis; portal hypertension; portal vein thrombosis (PVT); transjugular intrahepatic portosystemic shunts.
Conflict of interest statement
JT has received speaking and/or consulting fees from Versantis, Gore, Bayer, Alexion, Norgine, Grifols, and CSL Behring. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Portal Hypertension in Cirrhosis: From Pathogenesis to Novel Treatments
Publication types
LinkOut - more resources
Full Text Sources